Letters to the Editor

CAR-T therapy for relapsed/refractory large B-cell lymphoma in people living with HIV: efficacy, toxicity and treatment considerations.

Department of Haematology, University College London Hospitals, London
UCL Cancer Institute, University College London, London, UK; Cancer Research UK and UCL Cancer Trial Centre, UCL Cancer Institute, University College London, London
Department of Haematology, King’s College Hospital, London
Department of Haematology, Queen Elizabeth Hospital, Birmingham
Department of Haematology, University College London Hospitals, London
Department of Haematology, King’s College Hospital, London
Department of Haematology, University College London Hospitals, London
Department of Haematology, University College London Hospitals, London, UK; UCL Cancer Institute, University College London, London
Department of Haematology, Queen Elizabeth Hospital, Birmingham
Department of Haematology, University College London Hospitals, London
Department of Haematology, King’s College Hospital, London
Department of Haematology, University College London Hospitals, London, UK,; UCL Cancer Institute, University College London, London
Haematologica Early view Apr 2, 2026 https://doi.org/10.3324/haematol.2025.300151